Skip to content
Screener

AdaptHealth AHCO Investing Cash Flow

Investing Cash Flow at other companies

CVS Health logo
CVS HealthCVS
-$1.88B-84.0%
Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
-$281M+82.8%
Inogen logo
InogenINGN
-$3.13M+86.1%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
-$5.49M+35.7%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
-$1.26M+52.6%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$747.39M+3,190%

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$759.1M-39.9%
Enterprise value$2.71B-13.7%
P/S0.2×-0.2×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: AdaptHealth’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:21 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-030602
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Purchases of equipment and other fixed assets(121,212)(95,585)
Payments for business acquisitions(84,683)
Proceeds from the sale of assets1,439
Net cash used in investing activities(204,456)(95,585)
Cash flows from financing activities:
Proceeds from borrowings on lines of credit100,000
Repayments on long-term debt and lines of credit(14,063)(25,000)
Repayments of finance lease obligations(3,104)(3,221)

Item 1. Interim Consolidated Financial Statements (Unaudited)

FAQ

What is AdaptHealth's investing cash flow?
AdaptHealth (AHCO) reported investing cash flow of -$204.46M in Q1 2026.
How has AdaptHealth's investing cash flow changed year-over-year?
AdaptHealth's investing cash flow decreased by 113.9% year-over-year, from -$95.59M to -$204.46M.
What is the long-term trend for AdaptHealth's investing cash flow?
Over 4 years (2021 to 2025), AdaptHealth's investing cash flow has grown at a -35.7% compound annual growth rate (CAGR), from -$1.82B to -$312.79M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about AdaptHealth's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude